glp-1 and gip receptors vs. GLP-1 + GIP: What's the Difference for your Metabolism? gip and glp-1 receptor agonist

With repeat testing, higher results thus do not necessarily mean the patient is worse

Latin America Valued at USD 51.32 billion in 2024 , the nutritional supplements market is set to grow at a CAGR of 8.2% through 2030

Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formation

[32] found that exendin-4 mitigated resistance to the androgen receptor inhibitor enzalutamide in prostate cancer via the PI3K/AKT/mTOR pathway, suggesting that a combination of exendin-4 with enzalutamide may be a more effective therapeutic option for advanced prostate cancer

Without adequate protein and resistance training, your body composition changes will be suboptimal regardless of medications